Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Terfenadine will return to prescription-only status in the U.K. Sept. 16.

Executive Summary

U.K. RETURNING TERFENADINE TO Rx-ONLY STATUS EFFECTIVE SEPT. 16 to prevent misuse of the antihistamine, the U.K. Department of Health said Aug. 26. The agency is revoking pharmacist-supervised availability of terfenadine "following continuing reports of serious heart rhythm disorders when terfenadine is incorrectly used, despite warnings and precautions" on labeling and product leaflets.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts